Skip to Main Content

Paper Details

Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial.
Crit Care Med
4
2023
Author NameAffiliation
Andre C KalilUniversity of Nebraska Medical Center
Greg S MartinEmory University School of Medicine
Timothy G BuchmanEmory University School of Medicine
Carrie M RosenbergerInc.
  • 1 - 4

Datasets

Release 1.2